Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Tashanna K.N. Myers"'
Autor:
Angeles Alvarez Secord, Katherine Fuh, Thomas J. Herzog, Tashanna K.N. Myers, Reshma A. Rangwala, Bobbie J. Rimel, Kathleen N. Moore, Sharyn N. Lewin, Mary M. Mullen, Joyce F. Liu, Randy Anderson, Erika Hamilton, Thomas J. Reid, K.A. Mills
Publikováno v:
Journal of Clinical Oncology. 39:TPS5605-TPS5605
TPS5605 Background: The AXL receptor and its activating ligand, GAS6, are important drivers of metastasis and therapeutic resistance in human cancers. This signaling axis represents an attractive target for therapeutic intervention, but the strong pi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ab9ebbd8d15a0b6231c5bfe540a4e47b
https://doi.org/10.1200/jco.2021.39.15_suppl.tps5605
https://doi.org/10.1200/jco.2021.39.15_suppl.tps5605
Autor:
Summer G. Frank, Lisa M. Landrum, Kathleen N. Moore, Michael A. Gold, D. Scott McMeekin, Sara K. Vesely, Tashanna K.N. Myers, Joan L. Walker, Erin K. Alward, Robert S. Mannel
Publikováno v:
Cancer. 115:1472-1480
Patients agedor = 80 years who are diagnosed with advanced ovarian cancer (OC) have been reported to have a poor prognosis. In the current study, chemotherapy-related toxicity data were evaluated between patients agedor = 80 years and those aged80 ye
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::12cdd2a59c43d69efddc70bf9d962817
https://doi.org/10.1002/cncr.24190
https://doi.org/10.1002/cncr.24190
Autor:
Grainger S. Lanneau, Michael A. Gold, Joan L. Walker, Kathleen N. Moore, D. Scott McMeekin, Tashanna K.N. Myers, Lisa M. Landrum
Publikováno v:
Gynecologic Oncology. 112:337-341
Objective The pattern of metastasis for Stage IV endometrial carcinoma (EC) is similar to that for ovarian carcinoma (OC), hence the goal of surgical management for both diseases is optimal cytoreduction (CRS) followed by adjuvant chemotherapy. The o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::922766d57a85c5bb34cd1c9400b5da95
https://doi.org/10.1016/j.ygyno.2008.10.009
https://doi.org/10.1016/j.ygyno.2008.10.009
Autor:
Yuhong Tang, Lauren Cole, Shylet Chengedza, Daynelle Dedmond, Tashanna K.N. Myers, Yanfang Pan, Stan Lightfoot, Doris M. Benbrook
Publikováno v:
Investigational New Drugs
Summary Flexible heteroarotinoids (Flex-Hets) compounds regulate growth, differentiation and apoptosis in cancer cells. The hypothesis of this study was that the lead Flex-Het, SHetA2, inhibits angiogenesis by blocking cytokine release from cancer ce
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::14a1729d87528b78b48731095790adb3
https://doi.org/10.1007/s10637-008-9175-7
https://doi.org/10.1007/s10637-008-9175-7
Autor:
Joan L. Walker, Lisa M. Landrum, D.S. McMeekin, Tashanna K.N. Myers, Kathleen N. Moore, Michael A. Gold
Publikováno v:
Gynecologic Oncology. 108:342-347
Objective. Intraperitoneal (IP) chemotherapy has a clear survival advantage in patients with advanced ovarian cancer, but the high rate of complications has discouraged widespread acceptance. The purpose of this study was to review the completion rat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2c1e2a9dc23ff9516b68e42d36b59813
https://doi.org/10.1016/j.ygyno.2007.10.004
https://doi.org/10.1016/j.ygyno.2007.10.004
Autor:
Randy L. Carter, Laura J. Havrilesky, James Kauderer, Michael Rodriguez, Linda Van Le, Tashanna K.N. Myers, Sandra E. Brooks, Steven C. Plaxe, Janet G. Drake, Lisa M. Landrum, Joan L. Walker, Karen Basen-Engquist, Carol L. Brown
PurposeThe aim of this study was to identify patient and physician factors related to enrollment onto Gynecologic Oncology Group (GOG) trials.MethodsProspective study of women with primary or recurrent cancer of the uterus or cervix treated at a GOG
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::95105522169dbe14ba0ab146aec94c49
https://europepmc.org/articles/PMC4489417/
https://europepmc.org/articles/PMC4489417/
Publikováno v:
Female pelvic medicinereconstructive surgery. 19(4)
Background Endometrial carcinoma is rare after LeFort colpocleisis. Standards for its diagnosis and treatment have not been established. Case A 74-year-old woman presented with postmenopausal bleeding 14 months after LeFort colpocleisis. Here, we des
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4d22d47048b77f0c9d111fa11f3b03a4
https://pubmed.ncbi.nlm.nih.gov/23797524
https://pubmed.ncbi.nlm.nih.gov/23797524
Autor:
P. St. Marie, Tashanna K.N. Myers, R.M. Thibodeau, Christopher N. Otis, N.M. Kawar, L.L. Cole
Publikováno v:
Gynecologic Oncology. 141:97
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1570ad7f610a0d4e76b322edaf61b46b
https://doi.org/10.1016/j.ygyno.2016.04.267
https://doi.org/10.1016/j.ygyno.2016.04.267
Autor:
Monica S. Reid, Daniel N. Fong, Kathleen N. Moore, Lisa M. Landrum, Katherine M. Moxley, D. Scott McMeekin, Joan L. Walker, Robert S. Mannel, Tashanna K.N. Myers
Publikováno v:
Gynecologic oncology. 110(2)
The cornerstone of therapy for advanced ovarian cancer is cytoreductive surgery (CRS) followed by platinum based chemotherapy. Optimal management for very elderly women (80) is unclear. This study sought to review the experience with treating ovarian
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::57d29447577d557f06c850f24fee79a5
https://pubmed.ncbi.nlm.nih.gov/18495221
https://pubmed.ncbi.nlm.nih.gov/18495221
Autor:
D.S. McMeekin, Michael A. Gold, Kathleen N. Moore, Joan L. Walker, S.H. Elfrink, Tashanna K.N. Myers
Publikováno v:
Gynecologic Oncology. 111:380
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::10441eda5250316b41193cd302cfa743
https://doi.org/10.1016/j.ygyno.2008.07.078
https://doi.org/10.1016/j.ygyno.2008.07.078